Le Lézard
Classified in: Health
Subjects: MAV, CCA

WELL Health to Host Second Quarter 2019 Investor Conference Call


VANCOUVER, Aug. 19, 2019 /CNW/ - WELL Health Technologies Corp. ("WELL") (TSX.V: WELL), a company focused on consolidating and modernizing clinical and digital assets within the primary healthcare sector, will hold a call to discuss its 2019 second quarter financial results on Thursday August 22, 2019 at 1:00 pm ET (10:00 am PT). The call will be hosted by Hamed Shahbazi, Chairman and Chief Executive Officer; Eva Fong, Chief Financial Officer and Pardeep S. Sangha Vice President Corporate Strategy and Investor Relations.

Conference Call Details:
Date:  Thursday August 22, 2019
Time:  1:00 pm Eastern Time (10:00 am Pacific Time)
Dial-in:  1-416-764-8609 (Toronto local) or 1-888-390-0605 (Toll-Free)
Conference ID:  54030543

Replay accessible for 7 days:
Replay dial-in: 1-416-764-8677 or 1-888-390-0541
Playback passcode:  030543#

About WELL

WELL is a unique company that operates Primary Healthcare Facilities as well as a significant EMR or Electronic Medical Records business that supports the digitization of such clinics.  WELL's overarching objective is to empower doctors to provide the best and most advanced care possible leveraging the latest trends in digital health.  In the last 12 months, WELL physicians served approximately 600,000 patient visits through its network of 19 medical clinics.  WELL is publicly traded on the TSX Venture Exchange under the symbol WELL.V.  WELL was recognized as a TSX Venture 50 Company in 2018 and 2019.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE WELL Health Technologies Corp.


These press releases may also interest you

at 16:35
Agilent Technologies, Inc. today announced the pricing of an underwritten, registered public offering of a series of its senior notes in an aggregate principal amount of $500 million. The offering is being conducted under an automatic shelf...

at 16:35
Dicerna Pharmaceuticals, Inc. (the "Company" or "Dicerna"), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that the Compensation Committee of the Company's Board of Directors approved...

at 16:30
OpSense, a real-time continuous monitoring Software as a Service platform, today announced the release of an upgraded, feature-rich digital checklist application designed to meet the needs of retailers and food service operators. As businesses...

at 16:25
Xenon Pharmaceuticals Inc. , a clinical-stage biopharmaceutical company, announced today that Dr. Simon Pimstone, Xenon's Chief Executive Officer, will present a company overview at the Jefferies Virtual Healthcare Conference on Wednesday, June 3,...

at 16:16
The F.M. Kirby Foundation of Morristown, New Jersey, has given United Network for Organ Sharing (UNOS) $75,000 to help promote organ donations and increase the number of organ transplants during the COVID-19 pandemic....

at 16:16
StageZero Life Sciences Ltd. ("StageZero", or the "Company") is pleased to announce that it has filed a preliminary short form prospectus with the securities commissions or similar regulatory authorities in the Provinces of British Columbia,...



News published on 19 august 2019 at 18:56 and distributed by: